Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Decrease in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) saw a significant decline in short interest in October. As of October 15th, there was short interest totaling 28 shares, a decline of 56.9% from the September 30th total of 65 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 1,902 shares, the days-to-cover ratio is currently 0.0 days.

Innovator IBD Breakout Opportunities ETF Trading Down 2.0%

Shares of NYSEARCA:BOUT traded down $0.82 during trading on Friday, hitting $40.45. 1,823 shares of the company’s stock were exchanged, compared to its average volume of 3,481. Innovator IBD Breakout Opportunities ETF has a 1-year low of $35.05 and a 1-year high of $49.41. The firm has a 50-day moving average price of $43.11 and a two-hundred day moving average price of $43.37. The firm has a market cap of $14.16 million, a P/E ratio of 28.69 and a beta of 1.04.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.